BioMed Research International

Cervical Cancer Prevention: New Frontiers of Diagnostic Strategies


Status
Published

Lead Editor

1Vita Salute San Raffaele University, Milan, Italy

2UPMC Beacon Hospital, Dublin, Ireland

3University of Ioannina, Ioannina, Greece


Cervical Cancer Prevention: New Frontiers of Diagnostic Strategies

Description

Cervical cancer has definitely been demonstrated to be caused by high-risk Human Papillomavirus (hrHPV), and the biomolecular identification of HPV infection has dramatically changed the perspective of preventive strategies worldwide. Thirteen hrHPV types have been genotyped, of which HPVs 16 and 18 are the most frequently correlated with invasive cervical cancer, being identified in almost 90% of the cases; this causal relationship has strongly stimulated the introduction of hrHPV DNA testing in several clinical settings: primary screening, triage of cytological abnormalities, and after conservative treatment as a test of cure. The present years are characterized by a worldwide scientific debate, supported by the results of recent population-based studies that highlighted the need of a shift from cytological to molecular strategies of screening and prevention of cervical cancer. In this view, several innovative biomarkers have been investigated and encouraging results promise to open a new scenario in the near future.

Potential topics include, but are not limited to:

  • Biomarkers of hrHPV oncogenes transformation activity
  • Cytology-improving biomarkers
  • Cytology-hrHPV testing synergies in clinical practice
  • hrHPV genotyping in clinical practice
  • Epigenetics of cervical cancer
  • Immunology of HPV-related cervical preneoplastic and neoplastic disease
  • The future of colposcopy
  • Management of CIN lesions

Articles

  • Special Issue
  • - Volume 2015
  • - Article ID 250917
  • - Editorial

Cervical Cancer Prevention: New Frontiers of Diagnostic Strategies

Massimo Origoni | Walter Prendiville | Evangelos Paraskevaidis
  • Special Issue
  • - Volume 2015
  • - Article ID 561242
  • - Review Article

Current Advances in the Application of Raman Spectroscopy for Molecular Diagnosis of Cervical Cancer

Inês Raquel Martins Ramos | Alison Malkin | Fiona Mary Lyng
  • Special Issue
  • - Volume 2015
  • - Article ID 283036
  • - Research Article

HPV Testing from Dried Urine Spots as a Tool for Cervical Cancer Screening in Low-Income Countries

Elena Rosanna Frati | Marianna Martinelli | ... | Elisabetta Tanzi
  • Special Issue
  • - Volume 2015
  • - Article ID 614035
  • - Research Article

Accuracy of Colposcopically Directed Biopsy: Results from an Online Quality Assurance Programme for Colposcopy in a Population-Based Cervical Screening Setting in Italy

Mario Sideri | Paola Garutti | ... | Lauro Bucchi
  • Special Issue
  • - Volume 2015
  • - Article ID 304584
  • - Research Article

miR-34a and miR-125b Expression in HPV Infection and Cervical Cancer Development

Joana Ribeiro | Joana Marinho-Dias | ... | Hugo Sousa
  • Special Issue
  • - Volume 2015
  • - Article ID 605375
  • - Research Article

Underscreened Women Remain Overrepresented in the Pool of Cervical Cancer Cases in Spain: A Need to Rethink the Screening Interventions

Raquel Ibáñez | María Alejo | ... | Silvia de Sanjosé
  • Special Issue
  • - Volume 2015
  • - Article ID 984528
  • - Clinical Study

Long-Term Clinical Outcome after Treatment for High-Grade Cervical Lesions: A Retrospective Monoinstitutional Cohort Study

Annarosa Del Mistro | Mario Matteucci | ... | Daria Minucci
  • Special Issue
  • - Volume 2014
  • - Article ID 257807
  • - Research Article

Acceptability of Human Papillomavirus Vaccine: A Survey among Master of Business Administration Students in KwaZulu-Natal, South Africa

Muhammad Ehsanul Hoque | Guido Van Hal
BioMed Research International
 Journal metrics
Acceptance rate31%
Submission to final decision67 days
Acceptance to publication30 days
CiteScore3.600
Impact Factor2.276
 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.